The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
Haiyan ZhouFrancesco MuntoniPublished in: Journal of cachexia, sarcopenia and muscle (2020)